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Nerve Growth Factor Is an Autocrine Survival Factor
for Memory B Lymphocytes
Maria Torcia,*² Luisa Bracci-Laudiero,³ (Johnson et al., 1986; Shelton and Reichardt, 1986). It
is believed that NGF, like the other neurotrophins, isMaria Lucibello,* Lucia Nencioni,* Danilo Labardi,*
produced in the nervous system by accessory cells,Anna Rubartelli,§ Federico Cozzolino,* Luigi Aloe,³
such as glial cells and oligodendrocytes (Ernfors et al.,and Enrico Garaci*
1990; Hofer et al., 1990), which therefore regulate the*Department of Experimental Medicine
differentiation process of neurons mostly through theUniversity of Rome ªTor Vergataº
formation of paracrine circuits.Via di Tor Vergata 135
The neurotrophins, including NGF, brain-derived neu-I±00133 Rome
rotrophic factor, neurotrophin-3 (NT-3), and NT-4/5, ex-Italy
ert their effects on cellular targets via specific surface²Department of Clinical Physiopathology
receptors, which, upon binding and internalization ofUniversity of Florence
the ligand, trigger a cascade of biochemical events,Viale Pieraccini 6
representing the adaptive response (reviewed by Barde,I±50139 Florence
1990). Two classes of neurotrophin-binding sites canItaly
be identified on target cells, based on low (Kd ≈ 1 nM)³Institute of Neurobiology
and high (Kd ≈ 20 pM) affinity for the ligand or ligands. TheNational Research Council
molecular nature of these receptors has been recentlyViale Marx 15
characterized (Meakin and Shooter, 1992). A 75 kDaI±00185 Rome
glycoprotein, named p75NGFR, mediates low affinity bind-Italy
ing of any neurotrophin with similar affinity (Chao, 1994).§Service of Clinical Pathology
Proteins belonging to the family of trk tyrosine kinaseNational Institute for Cancer Research
receptors, which interact with neurotrophins in a highly
Viale Benedetto XV 10
specific manner, are responsible for high affinity binding.
I±16132 Genoa
p140trk-A combines with NGF, p140trk-B with brain-derived
Italy neurotrophic factor, and p140trk-C with NT-3 and NT-4/5
(Barbacid, 1994). Probably, each class of receptors con-
veys distinct signals to the target cell, since it appears
Summary that p75NGFR and p140trk-A do not form NGF-binding heter-
odimers (Jing et al., 1992). Interestingly, p75NGFR displays
Production of nerve growth factor (NGF) was assessed structural homology to the tumor necrosis factor recep-
in cultures of human T and B lymphocytes and macro- tors 1 and 2, the lymphocyte surface antigens CD30,
phages. NGF was constitutively produced by B cells CD40, OX40, and Fas/Apo-1 surface antigen, molecules
only, which also expressed surface p140trk-A and p75NGFR involved in preventing or mediating apoptosis (reviewed
by Raffioni et al., 1993).molecules and hence efficiently bound and internal-
Since the first description of the purification of NGFized the cytokine. Neutralization of endogenous NGF
from mouse maxillary gland cells, it was evident thatcaused disappearance of Bcl-2 protein and apoptotic
this factor was also produced by several nonnervousdeath of resting lymphocytes bearing surface IgG or
cell types (Levi-Montalcini, 1987), including keratino-IgA, a population comprising memory cells, while sur-
cytes (Di Marco et al., 1993) and smooth muscle cellsface IgM/IgD ªvirginº B lymphocytes were not af-
(Ueyama et al., 1993). Likewise, expression of the trkfected. In vivo administration of neutralizing anti-NGF
proto-oncogene has been reported by immune cells,antibodies caused strong reduction in the titer of spe-
such as monocytes (Ehrhard et al., 1993a) or T lympho-cific IgG in mice immunized with tetanus toxoid, ni-
cytes (Ehrhard et al., 1993b). It is therefore believed thattrophenol, or arsonate and reduced numbers of sur-
neurotrophins, particularly NGF, may subserve impor-face IgG or IgA B lymphocytes. Thus, NGF is an
tant roles outside the nervous system.autocrine survival factor for memory B lymphocytes.
These two lines of evidence, together with the struc-
tural homology of p75NGFR to a series of surface recep-
Introduction tors, including those for cytokines, and with the ob-
served elevated plasma levels of NGF in patients with
Nerve growth factor (NGF), described and characterized some autoimmune diseases (Dicou et al., 1993; Bracci-
more than 30 years ago (Levi-Montalcini, 1987; Cohen, Laudiero et al., 1993; L. B.-L, L. A., E. G., and G. Rasi,
1960) as the first soluble signal mediating intercellular unpublished data), led us to investigate whether NGF
communications, is a member of the family of proteins or its receptors or both were expressed by cells of the
known as neurotrophins, which are critical for regulated immune system.Here, we report that NGF is synthesized
development and survival of neuronal cells (Barde, and released under basal conditions by normal human
1990). Its role in maintaining survival of neurons from B lymphocytes, which also constitutively express both
sympathetic and sensory ganglia has been established p75NGFR and p140trk-A receptor chains. In addition, endog-
for decades (Levi-Montalcini and Angeletti, 1966, 1968). enous NGF functions in an autocrine fashion to maintain
In recent years, these initial observations have been viability of cells with the surface phenotype of memory
extended to other populationsof central nervous system B cells, and its neutralization in vivo abrogates a second-
ary humoral immune response.neurons, including basal forebrain cholinergic cells
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Results
NGF Production by Normal Human
Immunocompetent Cells
During the course of a study to assess plasma levels of
NGF in various pathological settings, we noticed that
particularly high amounts of cytokine were present in
patients with chronic liver diseases and other autoim-
mune conditions. To determine which cell type, if any,
among immunocompetent cells was responsible for
NGF production, normal peripheral blood or tonsil mo-
nonuclear cells were fractionated into T cells, B cells,
and monocytes. These cells were then cultured in the
presence or absence of relevant stimuli and subse-
quently tested for biochemical evidence of NGF synthe-
sis and secretion. Only B lymphocytes constitutively
produced NGF, and their generation of NGF was en-
hanced by stimulation with Staphylococcus aureus of
the I Cowan strain (SAC) (Figure 1A). Immunoblotting
demonstrated a major band in B lymphocyte±condi-
tioned medium with anti-NGF antibodies (Figure 1A), but
not with nonimmune immunoglobulin G (IgG) (data not
shown). Immunoprecipitation of metabolically labeled B
cell supernatants also showed a single major band with
Mr ≈ 13 kDa under reducing conditions or with Mr ≈
26 kDa under nonreducing conditions, the presence of
which was blocked by inclusion of excess unlabeled
NGF (Figure 1B). Kinetic studies of B cell lysates and
supernatants showed no NGF storage pool (data not
shown). In contrast with these results with B cells, no
NGF production was observed with T lymphocytes or
monocytes, even after stimulation (Figure 1A). Although
it has been reported quite recently that some T cell
clones can produce NGF (Ehrhard et al., 1993b), we
became convinced that such cells are scarcely repre-
sented in a normal peripheral blood or tonsil sample
(based on analysis of cell populations from at least
twenty different donors), and we therefore focused on
B cell production.
B lymphocytes were fractionated on density gradi-
ents, and high and low density fractions were studied
as representative of resting and in vivo activated cells,
respectively. Both B cell populations produced and effi-
ciently releasedNGF (the latter approximately 60%more
than the former; data not shown). Next, resting B cells
were stimulated with antibodies to the human immuno-
Figure 1. NGF Production by Normal Immunocompetent Cells globulin m chain constant region plus interleukin-4 (anti-
(A) Western blot analysis of culture supernatants from indicated m plus IL-4) or with SAC, two stimuli active on B cells;
human peripheral blood cells and mouse Swiss 3T3 fibroblasts as the former activating surface IgM1 cells only, and the
positive control. Human recombinant NGF was used as internal latter activating virtually all B lymphocytes (Romagnani
standard. Only B lymphocytes showed constitutive production of
NGF, which increased after SAC stimulation.
(B) Endogenous labeling of peripheral blood B cells and NGF immu-
noprecipitation. Supernatants from 35S-labeled B cells were immu-
noprecipitated with anti-NGF antibodies in absence (minus cold) or (D) Time-course analysis of NGF production by resting tonsil B lym-
presence (plus cold) of excess unlabeled NGF and analyzed by 15% phocytes cultured with either no stimulus (closed circle), SAC (open
SDS±polyacrylamide gel electrophoresis under reducing (RC) and box), or anti-m plus IL-4 (open triangle). NGF concentration in culture
nonreducing conditions (NRC). Immunoprecipitable endogenously supernatants was measured by ELISA. The value at time 0 shows
synthesized NGF was identified; detection of the NGF band was the level of NGF in cell lysates of freshly isolated B cells. SAC
blocked by excess unlabeled NGF. stimulation induced increase in cytokine production, which in con-
(C) Western blot analysis, immunostained with anti-NGF antibodies, trast gradually decreased in unstimulated or anti-m plus IL-4±
of supernatants from 12 hr cultures of resting tonsil B lymphocytes, stimulated cultures. The same analysis performed on cell lysates
separated by centrifugation through Percoll density gradients and revealed no NGF storage pool. The inset shows that resting B cells
cultured with either no stimulus (NIL), SAC, or anti-m plus IL-4. Only actively incorporated [3H±]thymidine when stimulated with either
SAC increased NGF production. SAC or anti-m plus IL-4.
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et al., 1982). It was evident that anti-m plus IL-4 stimula-
tion was ineffective, while SAC greatly enhanced NGF
synthesis and secretion (Figure 1C). Analysis of super-
natants of similar cultures by enzyme-linked immu-
noabsorbent assay (ELISA) confirmed that anti-m plus
IL-4±stimulated cells and unstimulated cells gradually
reduced NGF production, while SAC-stimulated cells
strongly increased it (Figure 1D). In contrast, both stimuli
were effective with respect to induction of proliferative
stimulation indices of greater than 10 and greater than
20, respectively (Figure 1D, inset). These findings indi-
cated that SAC, but not anti-m plus IL-4, triggered a
metabolic pathway leading to NGF production. An alter-
native explanation was that lymphocytes normally re-
sponding to anti-m plus IL-4, i.e., mostly virgin sm1d1
cells, did not alter NGF production (or possibly failed
to produce it) following surface immunoglobulin (sIg)
cross-linking, while the lymphocytes responding to SAC,
a population also comprising cells with sg1or sa1 (sg1/
a1) phenotype, did, suggesting that the cytokine was
involved in functional programs specific to the latter cell
type.
Expression of NGF Receptor Molecules by
Normal Human Immunocompetent Cells
The observation that NGF was produced by B lympho-
cytes prompted us to ascertain whether NGF receptors
were also present, making possible an autocrine feed-
back loop. To this purpose, tonsil or peripheral blood
T cells, B cells, and monocytes were studied for the
expression of the two NGF binding molecules that are
displayed by cells in the nervous system, the p140trk-A
(trk) and the p75NGFR.Western blot analyses of cell lysates
using specific antibodies showed that each of the cell
types studied expressed the trk molecule (Figure 2A);
interestingly, p75NGFR was produced by B cells only (Fig-
ure 2B). Moreover, the same cells were studied by FACS Figure 2. Expression of High Affinity (p140trk-A) and Low Affinity
following staining with antibodies to the p75NGFR chain (p75NGFR) NGF Receptors by Normal Immunocompetent Cells
and with Tmg 13.1, a recently described monoclonal (A) Western blot analysis and immunostaining with anti-trk antibod-
antibody (MAb) to the extracellular cytokine binding re- ies of lysates from resting B cells, in vivo activated (large) B cells,
T cells, and monocytes. The trk peptide used for rabbit immunizationgion of the trk molecule (Eager, 1991). Consistent with
and lysates from PC±12 cell line were used as positive controls;the immunochemical approach, double staining was ob-
lysates from K562 cell line were used as negative control.served on B cells only, while T cells and monocytes
(B) Western blot analysis and immunostaining with anti-p75NGFR anti-
were solely stained by Tmg 13.1 (data not shown). bodies of lysates from resting B cells, in vivo activated (large) B
The simultaneous expression of both receptor chains cells, T cells, and monocytes.
by B lymphocytes, a situation typical of nervous cells, High affinity NGF receptors were expressed by all immunocompe-
tent cell types, while low affinity NGF receptors were expressed byindicated that these cells were equipped to respond to
B lymphocytes only.the full range of signals conveyed by the cytokine. We
therefore concentrated on B cells, with the goal of ob-
taining data relevant to the functional role of NGF in
lymphocytes. binding sites per cell), respectively, consistent with the
data reported on nervous cells. Surprisingly, when theTo demonstrate binding of the cytokine, and to ana-
lyze its functional effects, we separated tonsil B lympho- same analysis was performed on small, resting B cells,
no saturable binding could be observed, even upon in-cytes into small and large cells and studied them for their
ability to bind and internalize NGF, using equilibrium cubation with very high 125I±NGF concentrations (data
not shown), in spite of the evident expression of bothbinding assays. Both resting and in vivo activated B
cells efficiently internalized 125I±NGF (data not shown). receptor chains (see Figure 2) and the efficient internal-
ization of the cytokine. This marked discrepancy led usFigures 3A and 3B show the saturation curves of
125I±NGF and their Scatchard transformations obtained to consider the possibility that the endogenous ligand
was actually occupying the receptor sites, a situationwith large and resting B cells. Large cells expressed, as
expected, two classes of binding sites, demonstrating frequently encountered when autocrine circuits are act-
ing (Cozzolino et al., 1989, 1990). Thus, purified small BKd ≈ 30 pM (3 3 104 sites per cell) and Kd ≈ 1 nM (106
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Figure 3. NGF Binding to B Lymphocytes
(A and B) Resting (closed box) or in vivo acti-
vated (open triangle) B cells were incubated
with two ranges of 125I±NGF concentrations in
order to saturate high and low affinity NGF
receptors.
(A) With NGF concentrations ranging be-
tween 10±400 pM, high affinity receptors
were evident on both resting (Kd ≈ 170 pM)
and in vivo activated lymphocytes (Kd ≈ 30
pM), with approximately 90,000 and approxi-
mately 30,000 binding sites per cell, respec-
tively.
(B) High affinity receptors were detected on
resting B lymphocytes after acidic treatment
only. With NGF concentrations ranging be-
tween 0.5±10 nM, low affinity receptors were
evident on both resting (closed box) and large
B lymphocytes (open triangle), with a Kd of
approximately 1 nM and approximately 106
binding sites per cell on both cell types.
(C) Endogenous NGF is tightly bound to sur-
face NGF receptors. Resting tonsil B cells
were washed with medium at pH 7.4 (NW,
neutral wash) or with medium buffered at pH
3.0 (AW, acidic wash). The eluted proteins
were TCA concentrated, blotted, and immu-
nostained with anti-NGF antibodies. Human
rNGF was used as positive control.
lymphocytes were briefly (60 s at 48C) treated with cul- diminished by 20%±30% (Table 1), initially suggesting
that NGF was involved in the proliferative response toture medium buffered at pH 3.0 and then washed with
regular medium before the binding assay. Under these SAC. However, addition of exogenous recombinant NGF
failed to increase [3H±]thymidine incorporation (Table 1),conditions, both high and low affinity (Kd ≈ 170 pM and 1
nM, respectively) receptors, with 9 3 104 and 106 binding
sites per cell, respectively, could be detected (Figures
Table 1. Effect of Anti-NGF Antibodies on Mitogen-Induced
3A and 3B). To strengthen further the hypothesis that Proliferation of Resting B Lymphocytes
these sites were indeed occupied by NGF because of
3H-thymidinethe existence of an autocrine loop, the acidic pH eluates
incorporation (cpm)
(and the neutral pH eluates, as controls) were run in
Exp. 1 Exp. 2 Exp. 3SDS±polyacrylamide gel electrophoresis, blotted, and
stained with specific anti-NGF antibodies. As predicted, UF B cells 251 240 306
the cytokine was detected in the acidic eluates only UF B cells 1 NGF 305 312 403
UF B cells 1 SAC 13,808 32,010 17,040(Figure 3C). Altogether, these results confirmed the ex-
UF B cells 1 SAC 1 anti-NGF 11,488 25,432 13,050pression of two classes of fully functional NGF receptors
UF B cells 1 SAC 1 goat IgG 13,765 32,456 17,321by B lymphocytes.
UF B cells 1 SAC 1 NGF 14,056 34,021 19,028
UF B cells 1 IL-4 1 anti-m 12,896 15,675 11,366
Effect of Endogenous NGF Neutralization UF B cells 1 IL-4 1 anti-m 1 anti-NGF 12,798 15,254 10,987
UF B cells 1 IL-4 1 anti-m1goat IgG 12,913 16,070 11,654in B Lymphocytes
UF B cells 1 IL-4 1 anti-m 1 NGF 13,004 16,876 12,114The above data, indicating that B cells produced NGF
and expressed high and low affinity receptors, sup- Purified sm1d1 cells 384 426 368
Purified sm1d1 cells 1 SAC 1 goat IgG 6,863 7,121 7,256ported the hypothesis of an autocrine circuit. To under-
Purified sm1d1 cells 1 SAC 1 anti-NGF 6,943 6,889 7,124stand the function exerted by this circuit, we neutralized
Purified sg1/a1 cells 279 344 368endogenous NGF and assessed its impact on properties
Purified sg1/a1 cells 1 SAC 1 goat IgG 13,935 14,759 13,157
of B lymphocytes. To this purpose, we employed either Purified sg1/a1 cells 1 SAC 1 anti-NGF 2,468 3,137 2,324
neutralizing antibodies to NGF or, in selected experi-
Resting unfractionated (UF) B lymphocytes or the indicated purifiedments, NGF antisense oligonucleotides. We first tested
populations were cultured for 48 hr and pulsed with 3H-thymidine
anti-NGF antibodies in conventional [3H±]thymidine in- in the last 12 hr. Data are expressed as mean 3H-thymidine incorpo-
corporation assays, using resting peripheral blood or ration of triplicate cultures. Standard deviation was always less than
tonsil B lymphocytes, stimulated with anti-m plus IL-4 10%. SAC was used at the final dilution of 1:10,000. Goat anti-NGF
antibodies or preimmune goat IgG were used at the concentrationor with SAC. Both stimuli induced a vigorous response
of 10 mg/ml. Recombinant human NGF was used at the concentra-in the presence of control preimmune antibodies; in
tion of 100 ng/ml. IL-4 was used at the concentration of 100 U/ml.the presence of anti-NGF antibodies, the response to
Polyclonal rabbit anti-m was used at the concentation of 1 mg/ml.
anti-m plus IL-4 was unaffected, while that to SAC was
NGF and Memory B Lymphocytes
349
even in the presence of suboptimal doses of stimulants
(data not shown), rather suggesting that the cytokine
was not acting as a growth factor. Consistently, sponta-
neous proliferation of low density in vivo preactivated
B cells was not modulated by anti-NGF antibodies
(data not shown). These stimulation experiments with
anti-m plus IL-4 or SAC again indicated that different
cell populations were responding to the mitogens and
that they could be functionally divided on the basis of
NGF utilization, in addition to NGF production (see also
Figure 1C). To gain support for this concept, we sepa-
rated resting tonsil B lymphocytes by panning into sm1d1
cells and sg1 and sa1 cells (sg1/a1), which were then
stimulated with SAC or anti-m plus IL-4. Table 1 shows
that proliferation of sm1d1 cells in response to SAC was
not affected by neutralizing anti-NGF antibodies. As ex-
pected, proliferation of sg1/a1 cells to anti-m plus IL-4
was very weak (data not shown), while these cells were
quite responsive to SAC; when stimulation was exerted
in the presence of anti-NGF antibodies, [3H±]thymidine
incorporation was reduced by more than 80% (p ,
0.0001). This finding, considered together with the re-
sults of the experiments on NGF production (see Figures
1C and 1D), suggested that the cytokine was critical for
sg1/a1 cells and apparently dispensable for sm1d1 cells.
These data led us to explore further the effects of
NGF on resting sm1d1 cells and sg1/a1 cells. Taking into
account that it failed to increase in vitro growth of B
cells (Table 1) and in view of the known property of NGF
to maintain survival of neuronal cells (in its absence,
those cells undergo apoptosis), we considered whether
NGF might enhance survival of resting sm1d1 cells or
sg1/a1cells. Thus, the above populations, purified from
tonsils, were cultured in the presence of anti-NGF anti-
bodies or NGF antisense oligonucleotides for various
time intervals, and the ratio of fragmented to intact DNA,
as a measure of the percentage of cells undergoing
apoptosis, was recorded. When sm1d1 cells were ana-
lyzed, equal proportions of cells were apoptotic, both
those treated with anti-NGF reagents and those with
control preimmune IgG (or sense oligonucleotide) (Fig-
ure 4A). In contrast, cultures of sg1/a1 cells treated with
anti-NGF antibodies or oligonucleotidescontained more
than 60% apoptotic cells at 60 hr, whereas control cul-
tures had less than 20% apoptotic cells (p < 0.0001)
(Figure 4B); interestingly, the kinetics of apoptosis were
much slower compared with that of sm1d1 cells, sug-
Figure 4. Effect of Anti-NGF Antibodies or Oligonucleotides onPuri- gesting an important difference in the life potential be-
fied B Cell Populations tween the latter cells and sg1/a1 cells in vitro.
(A and B) Resting sg1/a1 and sm1d1 B cells, purified by panning On the whole, this set of experiments demonstrated
procedures, were cultured in the presence of anti-NGF antibodies that endogenous NGF was an autocrine survival factor
(closed circle), control IgG (open circle), NGF antisense (closed box), for sg1/a1 cells, since its neutralization triggered their
or control sense (open box) oligonucleotides. At the indicated times,
apoptotic death, but not for sm1d1 cells, suggesting thatcells were lysed, and both nuclear and cytosolic DNA stained by
only the former cells could elaborate the cytokine. Todiphenylamine reagent. In sm1d1 B cells, anti-NGF antibodies or
test this concept, purified populations were analyzedNGF antisense oligonucleotides did not affect DNA fragmentation
kinetics (A), which was accelerated by NGF neutralization in sg1/ for NGF production by ELISA. It was evident that
a1 B cells (B). sg1/a1 cells produced at least 8-fold more NGF than
(C) Bcl-2 turnover in resting sg1/a1 and sm1d1 B cells following sm1d1 cells (409 6 19 pg/107 cells versus 51 6 4 pg/107
incubation with anti-NGF antibodies. Resting B cells, purified by
cells; n 5 9).panning procedures, were cultured in the presence of 10 mg/ml of
goat anti-NGF antibodies or of preimmune goat IgG (control) for 18
hr. At the end of incubation, cells were lysed, blotted on nitrocellu-
lose, and immunostained with anti±Bcl-2 MAbs. Bcl-2 protein com- but not with preimmune IgG. In contrast, anti-NGF antibodies did
pletely disappeared in sg1/a1 cells cultured with anti-NGF antibodies not affect Bcl-2 in sm1d1 B cells.
Cell
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Thus, to ascertain whether the functional difference
between the subsets was due to utilization, rather than
production, of NGF, we investigated an important deter-
minant of the pathway leading to apoptosis, Bcl-2 pro-
tein turnover (Korsmeyer, 1992). Purified resting sg1/a1
and sm1d1 populations were cultured with anti-NGF or
control antibodies for 18 hr and then lysed to analyze
their intracellular content of Bcl-2 protein. Figure 4C
shows that neutralization of endogenous NGF caused
the complete disappearance of Bcl-2 protein from
sg1/a1 cells but did not affect Bcl-2 protein content in
sm1d1 cells, revealing a major difference between the
subpopulations with respect to NGF utilization.
Anti-NGF Antibodies Deplete
Memory B Cells In Vivo
Since sm1d1 phenotype identifies virgin B cells, whereas
cells with sg1/a1 phenotype comprise those lympho-
cytes that have already undergone the process of immu-
noglobulin constant region class switch, including mem-
ory B lymphocytes (Kishimoto and Hirano, 1989; Sprent,
1994), we hypothesized that the autocrine NGF served
as a survival factor for memory B cells. We decided to
test this concept, using an in vivo approach to analyze
the well-defined hapten-specific systems Nitrophenol±
bovine serum albumin (NIP±BSA) or Arsonate±keyhole
limpet hemocianin (Ars±KLH), or the complex (mosaic)
antigen system tetanus toxoid (TT). First, we demon-
strated a substantial identity between human and mu-
rine B cells regarding NGF synthesis (murine sg1/a1 and
sm1d1 cells constitutively produced 234 6 21 pg/107
and 28 6 3 pg/107 cells, respectively), NGF receptor
Figure 5. Reduction of Antigen-Specific IgG Titer Induced by In Vivoexpression (murine unfractionated sIg1 cells expressed
Treatment with Anti-NGF Antibodiesapproximately 4,800 high affinity [Kd ≈ 135 pM] and ap-
We immunized three groups of twentymice with NIP±BSA, Ars±KLH,proximately 106 low affinity [Kd ≈ 1.1 nM] binding sites
or TT. After 40 days, ten mice of each group were treated with anti-per cell), and functional significance of the cytokine for
NGF antibodies (striped box), the others with preimmune IgG (open
cell survival in vitro (sg1/a1 cells presented approxi- box); 48 hr later, all animals were injected with a recall dose of the
mately 70% DNA fragmentation upon exposure to neu- relevant antigen. Serum levels of NIP-, Ars-, and TT-specific IgG (A)
tralizing anti-NGF antibodies). Thus, groups of twenty and IgM (B) were measured by ELISA 4 days after the recall injection.
The mean absorbance of serum samples in each group before theBALB/c or C57BL/6 mice were immunized with the rele-
antigen boost was subtracted from the values recorded at the endvant antigen, and after 40 days a group of ten animals
of the experiments (*p < 0.001).received a single dose of neutralizing anti-NGF IgG,
while the other ten mice were injected with nonimmune
IgG as control. After an additional 48 hr, all animals
The above findings suggest that, consistent with inreceived a recall dose of the respective antigen; 4 days
vitro data, anti-NGF antibodies were able to induce celllater, all mice were sacrificed, and plasma concentra-
death of most isotypically switched memory B cells,tions of antigen-specific IgM and IgG were determined
thus quenching a secondary humoral response. To ob-by ELISA. Animals receiving anti-NGF antibodies
tain direct evidence supporting this concept, we treatedshowed levels of specific IgG to the immunogen mark-
two groups of normal adult mice with anti-NGF IgG oredly lower than those of controls (p < 0.001) (Figure 5A).
with control IgG. After 3 days, spleen cells were isolated,In contrast, no difference was observed in the concen-
and the proportions of B cell subpopulations were as-tration of antigen-specific IgM (Figure 5B), indicating
sessed by cytofluorimetry. Figure 6 shows that the per-that the antibody response generated by the newly
centage of sg1/a1 cells was markedly reduced informed virgin B lymphocytes encountering the immuno-
spleens of treated mice, compared with controls, whilegen, the second primary response, was not affected. To
no significant difference between the two groups wasstrengthen further the latter conclusion, two additional
observed in the percentageof sm1d1 cells. On the whole,groups of mice were first treated with anti-NGF IgG or
this set of experiments indicates that NGF in vivo alsowith control IgG, then (48 hr later) immunized with TT,
plays a role in the maintenance of memory B cells.and after 1 week sacrificed to determine their plasma
level of TT-specific IgM, which was not statistically dif-
NGF Is Not a Switch Factor for B Lymphocytesferent in the two populations (0.275 6 0.032 absorbance
The outcome of the above in vivo NGF neutralization405 nm arbitrary units in treated animals versus 0.284 6
0.041 in controls) (data not shown). experiments was compatible with the hypothesis that
NGF and Memory B Lymphocytes
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Table 2. Effect of Anti-NGF Antibodies on Ig Production by
PWM-Stimulated PBMNC
Ig (ng/ml)
IgM IgG IgA
Medium alone 84 30 676
PWM 1,028 966 10,716
PWM 1 a-NGF 674 374 1,350
PWM 1 goat IgG 987 995 9,243
PWM 1 CD40m 1,530 554 4,794
PWM 1 CD4m 928 1,024 9,865
Human PBMNC were cultured at 3 3 106 cells/ml for 12 days in the
presence or absence of PWM (10 mg/ml), goat anti-NGF antibodies
or preimmune goat IgG (10 mg/ml), CD40m or CD4m supernatant
(1:10 final dilution). At the end of the incubation, supernatants were
collected and IgA, IgG, and IgM were measured by ELISA using
specific antibodies. Data are expressed as mean Ig concentration
of triplicate wells; standard deviation was less than 15%.
respective precursors, induced by anti-NGF antibodies.
These data are consistent with the results of the aboveFigure 6. In Vivo Effect of Anti-NGF Antibodies on Mouse Spleen B
in vivo experiments, whereby the reduction of sg1 orCell Subpopulations
sa1 cells was not accompanied by an increase of sm1Splenocytes from normal adult mice treated with neutralizing anti-
cells. As a whole, these findings strongly indicate thatNGF antibodies (1 mg/mouse) (striped box) or with preimmune goat
IgG (1 mg/mouse) (open box) were immunostained with antibodies NGF was not acting as a ªswitch factorº for normal
specific for the Fc region of mouse Ig m, Ig g, or Ig a chain, and human or murine B lymphocytes.
analyzed by flow cytometry. Percentage of sg1 or a1 B cells was
strongly reduced in mice treated with anti-NGF, compared with mice
treated with preimmune IgG. (*p < 0.001) Discussion
The ability to discriminate finely among a multitude ofthe cytokine was an autocrine survival factor for memory
B lymphocytes. However, the same results would have chemical structures and to retain a trace of these en-
counters (specificity and memory) are the hallmarks ofbeen observed if NGF were involved in the machinery
that governs the IgM→IgG class switch, along with the the immune system. While the molecular bases of speci-
ficity have been largely defined through the extensiveCD40 ligand (Aruffo et al., 1993). If this is true, however,
a higher proportion of IgM-producingcells, togetherwith characterization of the biochemistry and genetics of the
antigen receptors expressed by T and B lymphocytes,a reduced amount of IgG- or IgA-producing cells, should
be observed whenever a polyclonal population of lym- knowledge of immune memory is still largely phenome-
nological. In particular, it remains to be defined whetherphocytes is induced to differentiate in vitro in the pres-
ence of anti-NGF antibodies. Thus, normal human pe- a single memory cell, like most lymphocytes, has a defi-
nite and limited life span in quiescent conditions or isripheral blood mononuclear cells were cultured for 10
days with pokeweed mitogen to stimulate polyclonal a long-living cell lasting for years, possibly throughout
life. Several hypotheses have been proposed, the pre-differentiation (Kishimoto and Hirano, 1989), and with
either anti-NGF IgG or nonimmune IgG as negative con- vailing one being that the long persistence of antigen
within lymphoid organs results in a continuous slowtrols, or with soluble CD40 pentamer, a genetically
engineered molecule that prevents the CD40±gp39 in- proliferation of immune cells that maintain immunologi-
cal memory (Gray, 1993). However, it is difficult to imag-teraction (Fanslow et al., 1992) as a positive control.
Immunoglobulin measurement by ELISA revealed that ine how antigens can remain unmodified for years, par-
ticularly if proteinaceous (Sprent, 1994). In fact, evidenceanti-NGF antibodies induced a definite reduction in the
level of IgG and IgA in the pokeweed mitogen-stimulated has been provided that immunological memory can be
maintained for quite long periods by noncycling cellscultures, but also IgM levels approximately 20% lower
than those of control cultures (Table 2). By contrast, the (Schittek and Rajewsky, 1990), although the molecular
mechanisms allowing their survival are still unknown. Insoluble CD40 pentamer caused a depression of IgG and
IgA secretion compared with controls and an increase the present paper, we show evidence suggesting that
memory B lymphocytes, when generated, may undergoin the rate of IgM secretion (Table 2).
These experiments indicated a clear difference in the the same fate as Bizzozzero ªperennialº cells, whose
prototypes are neurons, because of their ability to pro-mechanisms likely to be responsible for the observed
changes. In fact, the soluble CD40 pentamer caused a duce an autocrine survival factor, NGF.
The major argument suggesting that the cytokine actsblock in the immunoglobulin class switch phenomenon,
inducing an ªaccumulationº of cells in the preswitch as a survival rather than a growth factor is based on the
observation that preventing NGF receptor triggering of(i.e., sm1) compartment; in contrast, anti-NGF antibodies
caused only a strong reduction of IgG- and IgA-produc- purified sg1/a1 resting B cells by neutralizing anti-NGF
antibodies caused massive cell death by apoptosis. Ining cells, an evidence of disappearance (death) of the
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addition, when resting unfractionated B cells were stim- both chains cooperate in binding a single molecule of
ligand, as conflicting results on this topic have beenulated with anti-m antibodies plus IL-4, which elicited a
strong proliferative response, they did not increase NGF reported (Jing et al., 1992; Benedetti et al., 1993; Huber
and Chao, 1995). However, it has been shown that ex-production rate and their proliferation was not aug-
mented by exogenous recombinant NGF, nor was it af- pression of p75NGFR induced neural cell death constitu-
tively when the protein was unbound, while its bindingfected by anti-NGF antibodies. Moreover, when SAC
was used to stimulate the same cells, increased by NGF or by monoclonal antibodies inhibited cell death
(Rabizadeh et al., 1993), suggesting that it is, per se,amounts of NGF were secreted, but further addition of
exogenous cytokine failed to potentiate [3H±]thymidine able to transmit a biological signal, consistent with the
structural homology between p75NGFR and a series ofincorporation, even if suboptimal doses of stimulant
were applied. Consistently, low density in vivo preacti- receptor chains, including TNFRI, TNFRII, Fas/Apo-1,
and CD40, all involved in inducing or preventingvated B cells expressed more NGF, but saturating doses
of anti-NGF antibodies did not abolish B cell prolifera- apoptosis in target cells (reviewed by Raffioni et al.,
1993). These latter data are entirely in accord with ourtion, as would be expected if the cytokine were a growth
factor. Taken together, these considerations instead finding that neutralization of the autocrine NGF, but not
treatment with anti-p75NGFR, determines B cell death (un-pointed to NGF as a survival factor.
This conclusion might appear to conflict with reports published data), pointing to this receptor chain as a
mediator of signals acting upon the survival±death di-that in the past years have suggested an intrinsic
growth-stimulating activity of NGF on lymphocytes (Ot- vide. Interestingly, in spite of the structural homology
between p75NGFR and CD40, it is clear that NGF does notten et al., 1989; Brodie and Gelfand, 1992). However,
these reports can be reinterpreted taking into account take part in the immunoglobulin class switch process.
In some cell types, such as keratinocytes or melano-that, according to our findings, addition of exogenous
NGF may reduce the number of some cells spontane- cytes (Yaar et al., 1994; Di Marco et al., 1993), trk medi-
ates signals that potentially stimulate cell proliferation,ously dying in vitro (particularly those originating IgA-
and IgG4-secreting cells; Kimata et al., 1991) because in contrast with what occurs in neuronal cells, whereby
NGF prevents apoptosis following trk engagement, pos-of low density culture conditions, eventually leading to
a higher basal proliferation in culture. Moreover, distinc- sibly via phosphatidylinositol-3 kinase activation (Yao
and Cooper, 1995). This discrepancy might be solvedtion between growth and survival factor may be purely
nominalistic, as suggested by the observation that IL-3 by the existence of another chain or chains that may
participate in the formation of a multichain receptorand stem cell factor support long-term survival of dor-
mant noncycling lymphohematopoietic progenitors in complex with trk or p75NGFR or both, as usually occurs
for most cytokine receptors. The latter hypothesis wouldliquid cultures (Katayama et al., 1993).
The finding of spontaneous production of NGF by B also explain the limited but significant difference we
observed in NGF binding affinities displayed by largecells lends furthersupport to theevidence of a phlogistic
role of NGF (Aloe et al., 1994), which probably contrib- and resting B cell populations (approximately 30 pM
versus approximately 170 pM, respectively; see Fig-utes in a paracrine fashion to the function of inflamma-
tory cells, such as macrophages, which are equipped ure 4).
Separation of normal resting B lymphocytes on thewith the receptor machinery necessary to respond to the
cytokine (Ehrhard et al., 1993a) but unable to produce it basis of surface immunoglobulin isotype expression
identifies two functionally different subpopulations; i.e.,(Santambrogio et al., 1994; Figure 1B, our data). Similar
considerations apply for T lymphocytes. In this study, sm1d1 virgin and sg1/a1 memory cells (Kishimoto and
Hirano, 1989). We used this approach to gain insightswe make no attempts to characterize more precisely,
from a phenotypic or functional standpoint, the (sub)- into the role of NGF autocrine circuit and observed sev-
eral features that led us to suggest that the cytokine ispopulations of T cells expressing NGF receptors and
hence probably responding to it. However, B cell± an endogenous survival factor for memory cells, both in
humans and in mice. First, while both virgin and memoryderived NGF might subserve important roles in the com-
plex event of B cell antigen presentation to T lympho- cells expressed basically the same levels of NGF recep-
tors, the latter produced at least 8-foldmore NGF proteincytes, particularly when a secondary immune response
has to take place. In fact, sIgG1 memory B cells express than the former. Second, treatment with neutralizing
anti-NGF antibodies induced disappearance of Bcl-2receptors with the highest affinity for the antigen (Sie-
kevitz et al., 1987; MacLennan and Gray, 1986) and are protein and, consistently, massive DNA fragmentation
in sg1/a1 cells, while it was insignificant for sm1d1 cells.therefore privileged in the competition for binding that
occurs when the antigen is in limited amounts. Their Third, invivo administration of anti-NGF antibodiesabol-
ished secondary antigen-specific immune responsesability to release NGF might be essential for a proper
activation of either memory or naive T cells. but failed to affect the primary IgM response. Finally, a
single injection of anti-NGF antibodies to normal animalsAn important point that has emerged from our study
is the simultaneous expression of both chains, the trk caused a marked reduction in the percentage of isotypi-
cally switched B lymphocytes, which comprise memorymolecule and the p75NGFR molecule, known to bind NGF
by B lymphocytes, a feature typically presented by neu- cells. On the other hand, these findings raise at least
two important issues, namely, the maturational stage atronal cells. Although NGF was the first cytokine to be
characterized, relatively little still is known about the which NGF gene expression takes place and the rela-
tionships between NGF and Bcl-2.specific metabolic pathways triggered by its interaction
with either receptor chain, nor is it clear whether or not The low but detectable production of NGF by sm1d1
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by adherence on plastic petri dishes. B lymphocytes were furthercells would indicate a relatively early onset during B
purified from the non-T population using CD19-coated magneticcell ontogeny, whose functional significance should be
beads. Murine B lymphocytes, depleted of monocytes as above,further elucidated. However, based on quantitative con-
were isolated from spleens by two rounds of negative selection
siderations about the magnitudes of different B cell sub- using an anti-CD3e MAb (Boehringer Mannheim).The purity of popu-
populations, it was suggested that sm1 cells also com- lation was more than 95%, as assessed by flow cytometry. Human
or murine B cells were further fractionated into resting (high density)prise memory lymphocytes, able to originate cells
and activated (low density) cells by Percoll density gradients. Thesecreting immunoglobulin other than IgM (Gray, 1993).
proportions of sIgM1, sIgG1, and sIgA1 cells in tonsil resting B cellsIf so, the sm1 cell-derived NGF we observed could be
were typically 65%, 25%, and 10%, respectively, as assessed byproduced by the latter cells and, in this case, NGF gene
flow cytometry.
expression might be linked to, and possibly regulated For proliferation assays, B cells were cultured in 96-well plates
by, the same molecular mechanisms operating the im- at a concentration of 106/ml in RPMI 1640 medium (GIBCO), supple-
mented with 10% (v/v) fetal calf serum (Hyclone), for 72hr in humifiedmunoglobulin class switch.
air with 5% CO2. Heat-inactivated SAC (Boehringer Mannheim) wasLittle is presently known about the molecular path-
used at the final dilution of 1:10,000. Human rIL-4 (R & D) was usedways that relate NGF receptor chains to Bcl-2, a protein
at 100 U/ml, rabbit anti-human chain was used at 1 g/ml, NGFcritically regulating survival both in neurons and in
(Boehringer Mannheim) was used at 100 ng/ml, neutralizing goat
lymphoid cells, particularly in memory B cells (Batistatou anti-NGF antibodies (R & D; ND50 5 10 mg/ml in the IMR±32 neuro-
et al., 1993; Hawkins and Vaux, 1994; Nunez et al., 1991), blastoma cell proliferation assay [Janet et al., 1995] in response to
which in fact disappears from resting sIgG1 or sIgA1 100 ng/ml of NGF) or preimmune goat IgG were used at 10 mg/ml.
Cells were pulsed with 0.5 mCi of [3H±]thymidine in the last 12 hr ofcells treated with neutralizing anti-NGF antibodies. Re-
culture and counted in a b scintillation counter.cently, evidence has beenprovided that reactive oxygen
For immunoglobulin production, human peripheral blood mono-species and, more generally, alterations in the cellular
nuclear cells were cultured for 12 days in the presence or absence
redox potential may be involved (Greenlund et al., 1995). of pokeweed mitogen (10 mg/ml, GIBCO), anti-NGF antibodies (10
In this connection, it has been shown that low-rate nitric mg/ml), preimmune goat IgG (10 mg/ml), and CD40-m or CD4-m su-
oxide production in Epstein±Barr virus-infected B lym- pernatant (1:10 final dilution). Supernatants were collected and
tested for IgG, IgA, and IgM production by ELISA.phocytes, constitutively expressing nitric oxide syn-
For analysis of NGF production, cells (2 3 107) were culturedthase, prevents apoptosis (Mannick et al., 1994), proba-
at 107/ml in serum-free RPMI 1640, supplemented with 10% (v/v)bly acting at multiple levels on thiol-sensitive pathways
Nutridoma (Sigma) for different times in the presence or absence ofthat also regulate metabolism of Bcl-2, susceptible to
SAC (1:10,000 final dilution), phytohemoagglutinin (1 mg/ml, GIBCO),
intracellular redox potential and participating in its main- lipopolysaccharide (10 mg/ml, Sigma), and supernatants assayed
tainance (Hockenbery et al., 1993). Interestingly, Mo- by ELISA.
B cell subpopulations were isolated by panning procedures usingsialos et al. (1995) quite recently showed that functional
plastic petri dishes coated with rabbit anti-human IgM and rabbitrelationships exist among the proteins that transduce
anti-human IgD (referred to as sm1d1), or rabbit anti-human IgG plussignals from the TNF±Fas±NGF receptor family; since
rabbit anti-human IgA (referred to as sg1/a1), or goat anti-mouseTNF induces alterations in cellular redox equilibrium
IgM and IgD or IgG and IgA, prepared as described in Wysocki and
(Ishii et al., 1992), these molecules could also participate Sato (1978). The purity of the isolated population was always greater
in the adaptive response elicited by NGF. We are pres- than 90%, as assessed by flow cytometry using specific MAbs.
ently investigating the latter hypothesis in memory B To rule out the interference of the activation process following sIg
receptor triggering, all the experiments were repeated using thecells following NGF neutralization.
reciprocal nonadherent populations (e.g., sm2d2 cells, mostly com-One striking piece of evidence deserving consider-
prising sg1/a1 cells), recovered after three rounds of adherenceation is the observation that, in lymphoid cells at least,
from immunoglobulin-coated plates.
both apoptosis and cell survival are regulated through
autocrine circuits, the former involving Fas/Apo-1 and Determination of Cell Viability and DNA Fragmentation
its ligand (Brunner et al., 1995; Dhein et al., 1995; Ju et Human and murine B cell subpopulations, cultured at 5 3 106/ml
al., 1995), the latter involving NGF, according to our with 10 mg/ml anti-NGF IgG or preimmune IgG, or with 20 mM 18-
mer antisense or sense oligonucleotides complementary to the nu-data. Such an arrangement ensures that all the molecu-
cleotides 54±72 of the NGF coding region (Primm), were dilutedlar requirements needed to commit the cell to either
1:1.5 with 5 mM Tris, 20 mM EDTA, and 0.5% (v/v) Triton X±100 (pHpathway are immediately available and helps us under-
8.0) and allowed to lyse for 15 min on ice before centrifugation forstand how lymphoid organs are sites in which complex
20 min at 27,000 3 g, to separate intact chromatin (pellet) from DNA
functional changes may occur in an ordered manner. fragments (supernatant). Pellets wereresuspended in 5 ml of a buffer
The evidence that the autocrine circuit is public (involv- containing 10 mM Tris and 1 mM EDTA (pH 8.0), and pellet and
ing secretion of ligands and binding to extracellular re- supernatant samples were assayed for DNA content, using the di-
phenylamine reagent (1.5% diphenylamine in acetic acid plus 10%ceptors) instead of private, or intracrine, strongly sug-
acetaldehyde) for 16 hr at 308C (Burton, 1956). The optical densitygests that function of both systems may be modulated
at 600 nm was measured for each sample. Percentage of DNAby either receptor antagonists or soluble receptors, orig-
fragmentation was calculated according to McConkey et al. (1989).
inating a complex network of ªsocialº controls over the Cell viability was evaluated by trypan blue dye exclusion.
fate of a single lymphocyte. Interestingly, the latter com-
plexity may yield several opportunities to interfere with Radioligand Binding Studies
such dynamics using pharmacological approaches. For analysis of surface NGF receptors, human resting tonsil or mu-
rine splenic B lymphocytes were acid-treated with RPMI 1640 me-
dium buffered at pH 3.0 for 1 min on ice and washed with phosphate-Experimental Procedures
buffered saline (PBS). Acid-treated resting B lymphocytes and in
vivo activated large B lymphocytes were then incubated at 106/mlCell Isolation and Culture
with different concentrations of 125I-NGF (Amersham; specific activ-Human T lymphocytes were separated from peripheral blood mono-
nuclear cells or tonsil cells by E-rosetting. Monocytes were isolated ity 50 mCi/g), in the presence or absence of excess unlabeled human
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rNGF for 2 hr at 48C. Cells were washed, and bound radioactivity by coating the plates with NIP±BSA or Ars±KLH. After saturation
with PBS containing 1% BSA and rinsing with PBS with 0.05%was counted in a g counter. Specific binding was calculated for
each experimental point, and data were analyzed by a scientific (v/v) Tween 20, coated wells were incubated for 1 hr at 378C with
serial dilution of mouse sera; a pool of preimmune mouse sera wasprogram (Figure P, Biosoft). For radioligand internalization, cells
were cultured as above with 0.5 nM 125I-NGF in the presence or used as negative control. Bound immunoglobulin were detected by
addition of alkaline phosphatase±conjugated goat anti-mouse IgGabsence of excess unlabeled NGF, washed and cultured at 378C
for 2 hr, then treated with glycin buffer (pH 2.8) and lysed. Mem- or IgM. The final reaction was visualized by incubating with NPP
(Sigma)substrate solution, andabsorbance at 405 nmwas recorded.brane-bound (acidic eluate) and cell-associated radioactivity were
determined by counting in a g-counter. The neutral pH wash and
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